Seventy-seven pharmaceutical companies have received long-pending dues amounting to Rs387 million after the intervention of the Federal Ombudsman, 24NewsHD reported.
According to details, the 77 companies had been awaiting the payment of their dues for the past several years. The Federal Ombudsman took notice of the matter and issued directives to the Drug Regulatory Authority of Pakistan (DRAP), after which the outstanding payments were released.
Federal Ombudsman Ejaz Ahmad Qureshi directed DRAP to resolve the issue within three months, following which the dues were cleared.
Ejaz Ahmad Qureshi said that timely payment of dues to pharmaceutical companies is essential for the uninterrupted supply of medicines.
Investigation revealed that the dues had been pending for several years, with many companies awaiting payments of Rs5 million or more.

Leave a Reply